Thursday, July 9, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ERNA”

213 pharma patents match "ERNA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 213
Index total 30,257
Page 5 / 9

Quick answer

This filtered view shows 213 pharmaceutical patents matching "ERNA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

213 results for “ERNA” · 30,257 patents in full index Clear search

  1. US 9592291

    Methods for iontophoretically treating nausea and migraine

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  2. US 9593162

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  3. US 9585863

    Treatment of cataplexy

    Jazz Pharmaceuticals International III Limited · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted

  4. US 9567402

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  5. US 9427578

    Pharmacokinetics of iontophoretic sumatriptan administration

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  6. US 9388244

    Internalizing ErbB2 antibodies

    The Regents of the University of California · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  7. US 9359290

    Treatment of cataplexy

    Jazz Pharmaceuticals International III Limited · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  8. US 9359418

    Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  9. US 9328200

    Branched polymeric quaternary ammonium compounds and their uses

    ULTRASCI DISCOVERY LLP · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  10. US 9272137

    Transdermal methods and systems for the delivery of anti-migraine compounds

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  11. US 2016030472

    XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY

    AIR LIQUIDE SANTÉ INTERNATIONAL [FR] · Granted Feb 4, 2016 · Expires Jan 30, 2036

    granted

  12. US 9226910

    Treatment for obesity

    Jazz Pharmaceuticals International III Limited · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  13. US 9216971

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  14. US 9180113

    Tocotrienol compositions

    First Tech International Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  15. US 9139525

    N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  16. US 9115145

    Tocotrienol derivatives and associated methods

    First Tech International Limited · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  17. CA 2938043

    MELANGE GAZEUX NO/HE A ACTION BACTERICIDE

    AIR LIQUIDE SANTE (INTERNATIONAL) [FR] · Granted Aug 6, 2015 · Expires Aug 1, 2035

    granted

  18. US 8974792

    Internalizing erbB2 antibodies

    The Regents of the University of California · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted

  19. US 8969303

    Tocotrienol esters

    First Tech International Limited · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  20. US 8962297

    Bacteriophage lytic enzymes as alternative antimicrobials

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  21. US 8937046

    Modulating the alternative complement pathway

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  22. US 8911733

    Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  23. US 8912172

    Skin external preparation containing triterpenic acid

    KURARAY CO., LTD. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  24. US 8912175

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.